Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
iCardiac Technologies, a provider of cardiac safety assessment services to the pharmaceutical industry, has added respiratory and ePRO services to its suite of offerings through the acquisition of the clinical trials division of nSpire Health.
read more
Wednesday, December 05, 2018
Icagen has entered into a license and collaboration agreement with Roche to develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders.
read more
Icagen, Inc., a provider of services and expertise for ion channel and transporter drug discovery and development, has announced that the company is consolidating its research operations and relocating corporate headquarters to its facility in the ...
read more
Icagen, Inc. announced today that the acquisition of Sanofi's ultra high-throughput biology, screening and chemistry capabilities and research facility in Oro Valley, Arizona (located nearTucson, Arizona) is officially complete.
read more
Icagen, Inc. announced that Dr. Chris Mathes has been appointed Chief Commercial Officer to help drive Icagen's expanding drug discovery and ion channel services business.
read more
Tuesday, January 10, 2017
Drug discovery services and products provider Icagen, Inc. has announced an agreement with Japan-based drug discovery sales specialist On Target Co., Ltd. granting On Target Company, Ltd. rights to broker Icagen's products and services in this ...
read more
Thursday, August 29, 2019
iBio has entered into a Master Services Agreement with Lung Biotechnology PBC to produce recombinant human collagen-based bioink for 3D bioprinted organ transplants.
read more
iBio introduced new cGMP sterile fill-finish capabilities for pharmaceutical products, including monoclonal antibodies, viral vectors, and other biologics.
read more
iBio, Inc., a company working on plant-based biotechnology for developing and manufacturing biological products, has announced the formation of a joint venture with affiliates of Eastern Capital Limited to develop and manufacture plant-made ...
read more
Wednesday, March 07, 2018
iBio announced the expansion of its CDMO capabilities and services to include the development and cGMP manufacturing of Fc fusion proteins for therapeutic pharmaceutical applications.
read more
iBio announced the activation of its new cGMP sterile fill-finish services operation via the signing of a supply agreement with a clinical-stage biopharmaceutical company.
read more
TraceLink announced that IBI Lorenzini has selected TraceLink's solutions to ensure compliance with global serialization regulations.
read more
IBC Life Sciences, an Informa business dedicated to providing rich conference content, valuable connections and business development opportunities, today opened the 11th Annual Single-Use Applications 2014 conference with the news that it will ...
read more
The International AIDS Vaccine Initiative (IAVI) has been awarded a new contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) to expedite the development of promising ...
read more
Wednesday, November 17, 2021
U.S.-based IACT Health and Canada-based LMC Manna Research announced a strategic alliance to integrate their operations. As two of the clinical research industry’s most extensive site networks, the alliance creates one of the largest consolidated ...
read more